Precipio (NASDAQ:PRPO) Issues Quarterly Earnings Results

Precipio (NASDAQ:PRPO) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, Zacks reports. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%.

Precipio Trading Down 7.1 %

Shares of PRPO opened at $6.18 on Friday. The stock has a market capitalization of $9.16 million, a PE ratio of -3.38 and a beta of 1.37. The company’s fifty day moving average is $7.12 and its 200 day moving average is $6.49. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.73. Precipio has a fifty-two week low of $4.31 and a fifty-two week high of $10.74.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.